AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2014
Feb 19, 2014
29755_dirs_2014-02-19_d2c375f2-cc61-46ca-8b30-df4e6b41d4b1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2014-02-18
Reporting Person: HURWICH THOMAS A. (VP, Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-18 | Common stock, $0.01 par value | M | 9138 | $44.93 | Acquired | 61016 | Direct |
| 2014-02-18 | Common stock, $0.01 par value | F | 8428 | $50.73 | Disposed | 52588 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-02-18 | Option (right to buy) | $44.93 | M | 9138 | Disposed | 2014-02-19 | Common stock (9138) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $0.01 par value | 403 | Indirect |
| Common stock, $0.01 par value | 274 | Indirect |
Footnotes
F1: Balance in AbbVie Savings Program as of February 18, 2014.
F2: The reporting person disclaims beneficial ownership of all securities held by his spouse.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4